메뉴 건너뛰기




Volumn 42, Issue 9, 2007, Pages 1070-1072

Pro-MMP-9 is associated with poor prognosis in gastric cancer

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

EID: 34548134479     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701435881     Document Type: Article
Times cited : (7)

References (7)
  • 2
    • 0030016640 scopus 로고    scopus 로고
    • Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
    • Sier CF, Kubben FJ, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JH, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-7.
    • (1996) Br J Cancer , vol.74 , pp. 413-417
    • Sier, C.F.1    Kubben, F.J.2    Heerding, M.M.3    Griffioen, G.4    Hanemaaijer, R.5    van Krieken, J.H.6
  • 4
    • 0009683601 scopus 로고    scopus 로고
    • Plasma concentration of matrix metalloproteinase 9 in gastric cancer
    • Torii A, Kodera K, Uesaka T, Hirai T, Yasui K, Morimoto T, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg 1997;84:133-6.
    • (1997) Br J Surg , vol.84 , pp. 133-136
    • Torii, A.1    Kodera, K.2    Uesaka, T.3    Hirai, T.4    Yasui, K.5    Morimoto, T.6
  • 5
    • 0030800319 scopus 로고    scopus 로고
    • Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
    • Endo K, Maehara Y, Baba H, Yamamoto M, Tomisaki S, Watanabe A, et al. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res 1997;17:2253-8.
    • (1997) Anticancer Res , vol.17 , pp. 2253-2258
    • Endo, K.1    Maehara, Y.2    Baba, H.3    Yamamoto, M.4    Tomisaki, S.5    Watanabe, A.6
  • 7
    • 0037100983 scopus 로고    scopus 로고
    • A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
    • Bramhall SR, Schulz J, Nemunaitis J, Brown PD, Baillet M, Buckels JA. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 2002;87:161-7.
    • (2002) Br J Cancer , vol.87 , pp. 161-167
    • Bramhall, S.R.1    Schulz, J.2    Nemunaitis, J.3    Brown, P.D.4    Baillet, M.5    Buckels, J.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.